Trial Profile
The VICTORIA Study (Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation) Comparison Anti-vitamin K Versus Anti-Xa.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2019
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Fluindione; Warfarin
- Indications Atherosclerosis; Pulmonary embolism; Thrombosis
- Focus Therapeutic Use
- Acronyms VICTORIA
- 05 Nov 2019 Status changed from recruiting to completed.
- 24 Jul 2014 New trial record